SEC Form 4 insider trading filings tracked in real time from EDGAR

Yocca Frank — Chief Scientific Officer

Insider trading activity for Yocca Frank sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Scientific Officer
  • Company: BioXcel Therapeutics, Inc.
  • Total insider trades: 2
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: May 7, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
May 1, 2026 Yocca Frank BTAI BioXcel Therapeutics, Inc. OTHER 9,000 N/A
May 1, 2026 Yocca Frank BTAI BioXcel Therapeutics, Inc. OTHER 9,000 N/A

← All executives · Full trades feed